DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

Inclusion Criteria: * Consistent with the diagnosis of AML * Age≥18 years at time of consent * KPS(Karnofsky Performance Scale) ≥70 * Patient's written informed consent * No steroid therapy within 4 weeks of first DC vaccination * Stable disease, complete response and partial response(WHO, RECIST) * Predicted survival≥3 months Exclusion Criteria: * Serious dysfunction of vital organs(heart, liver or kidney) * Received organ transplantation * Patients with other malignancies or brain metastases * History of autoimmune diseases * Pregnant and breast-feeding patient * Active or chronic infectious diseases * History of allergy or hypersensitivity to study product excipients * Currently participating in another clinical trial * Received chemotherapy, radiotherapy, immune inhibitor (such as corticosteroid) or other immunotherapy (such as vaccine) during prior 4 weeks * Unfit for participating in this clinical trial in investigators' opinions